The ACHIEVE study is one of six that are part of a global collaborative effort to evaluate the noninferiority of 3-month vs 6-month oxaliplatin-based adjuvant chemotherapy in patients with stage III colon cancer.
A new study looked at median overall survival for patients with prior antibiotic therapy compared with patients with no prior antibiotic therapy.
How much do you know about the role of long non-coding RNAs in ovarian cancer? Now is your chance to find out.
Prognostic signature associated with AML relapse risk potential harbors gene subsets that apply to only certain patient subgroups.
In this study, FLT3-IRAK1/4 inhibitor (NCGC1481) removed adaptively resistant FLT3-mutant AML cells.
Age disparities in oncology trials are continuing, despite concerns raised over this issue.
A new study evaluated whether the m7-FLIPI score in patients with follicular lymphoma treated with rituximab without chemotherapy can indicate prognosis.
Researchers conducted a study to determine if low levels of immune infiltration were associated with inferior outcomes among patients with follicular lymphoma.
Cancer Network spoke with Dr. Jennifer A. Ligibel on the diet and exercise interventions to reduce breast cancer recurrences.
Two doctors discuss their research on how use of alternative over traditional medicine affects survival rates in patients with cancer and how oncologists can approach the age of medical misinformation.